1. Dulon M, Weichenthal M, Blettner
M, et al. Sun exposure and number of nevi in 5- to 6-year-old
European children. J Clin Epidemiol. 2002;55(11):1075-1081.
2. Schaffer JV. Pigmented lesions in children: when to worry. Curr
Opin Pediatr. 2007;19(4):430-440.
3. Valiukeviciene S, Miseviciene I, Gollnick H. The prevalence
of common acquired melanocytic nevi and the relationship with skin type
characteristics and sun exposure among children in Lithuania. Arch
Dermatol. 2005;141(5):579-586.
4. Whiteman DC, Brown RM, Purdie DM, Hughes MC. Melanocytic nevi
in very young children: the role of phenotype, sun exposure, and
sun protection. J Am Acad Dermatol. 2005;52(1):40-47.
5. Siskind V, Darlington S, Green L, Green A. Evolution
of melanocytic nevi on the faces and necks of adolescents: a 4 y
longitudinal study. J Invest Dermatol. 2002;118(3):500-504.
6. Oliveria SA, Saraiya M, Geller AC, et al. Sun exposure and
risk of melanoma. Arch Dis Child. 2006;91(2):131-138.
7. Lee TK, Rivers JK, Gallagher RP. Site-specific protective
effect of broad-spectrum sunscreen on nevus development among white schoolchildren
in a randomized trial. J Am Acad Dermatol. 2005;52(5):786-792.
8. Autier P, Doré JF, Cattaruzza MS, et al. Sunscreen
use, wearing clothes, and number of nevi in 6- to 7-year-old European
children. J Natl Cancer Inst. 1998;90(24):1873-1880.
9. MacLennan R, Kelly JW, Rivers JK, Harrison SL. The Eastern Australian
Childhood Nevus Study: site differences in density and size of melanocytic
nevi in relation to latitude and phenotype. J Am Acad Dermatol. 2003;48(3):367-375.
10. Synnerstad I, Nilsson L, Fredrikson M, Rosdahl I. Frequency and
distribution pattern of melanocytic naevi in Swedish 8-9-year-old
children. Acta Derm Venereol. 2004;84(4):271-276.
11. Zalaudek I, Hofmann-Wellenhof R, Soyer HP, et al. Naevogenesis:
new thoughts based on dermoscopy. Br J Dermatol. 2006;154(4):774-807.
12. National Institutes of Health Consensus Development Panel
on Early Melanoma. Diagnosis and treatment of early melanoma. JAMA. 1992;268(10):1314-1319.
13. Gandini S, Sera F, Cattaruzza MS, et al.
Meta-analysis of risk factors for cutaneous melanoma: I. Common
and atypical naevi. Eur J Cancer. 2005;41(1):28-44.
14. Pho L, Grossman D, Leachman SA. Melanoma genetics:
a review of genetic factors and clinical phenotypes in familial
melanoma. Curr Opin Oncol. 2006;18(2):173-179.
15. Bishop JN, Harland M, Randerson-Moor J, Bishop DT. Management
of familial melanoma. Lancet Oncol. 2007;8(1):46-54.
16. Kolm I, Di Stefani A, Hofmann-Wellenhof R, et al. Dermoscopy
patterns of halo nevi. Arch Dermatol. 2006;142(12):1627-1632.
17. Patrizi A, Neri I, Sabattini E, et al. Unusual inflammatory
and hyperkeratotic halo naevus in children. Br J Dermatol. 2005;152(2):357-360.
18. Zembowicz A, Mihm MC. Dermal dendritic
melanocytic proliferations: an update. Histopathology. 2004;45(5):433-451.
19. Boikos SA, Stratakis CA. Carney complex: the
first 20 years. Curr Opin Oncol. 2007;19(1):24-29.
20. Morgan CJ, Nyak N, Cooper A, et al. Multiple Spitz naevi:
a report of both variants with clinical and histopathological correlation. Clin
Exp Dermatol. 2006;31(3):368-371.
21. Argenziano G, Zalaudek I, Ferrara G, et al. Involution:
the natural evolution of pigmented Spitz and Reed nevi? Arch
Dermatol. 2007;143(4):549-551.
22. Brunetti B, Nino M, Sammarco E, Scalvenzi M. Spitz naevus:
a proposal for management. J Eur Acad Dermatol Venereol. 2005;19(3):391-393.
23. LeBoit PE. “Safe” Spitz and its alternatives. Pediatr
Dermatol. 2002;19(2):163-165.
24. Barnhill RL. The spitzoid lesion: rethinking Spitz tumors, atypical
variants, “spitzoid melanoma” and risk assessment. Mod
Pathol. 2006;19(suppl 2):S21-S33.
25. Jaramillo-Ayerbe F, Vallejo-Contreras J. Frequency and clinical
and dermatoscopic features of volar and ungual pigmented melanocytic
lesions: a study in schoolchildren of Manizales, Colombia. Pediatr
Dermatol. 2004;21(3):218-222.
26. Goettmann-Bonvallot S, Andre J, Belaich S. Longitudinal
melanonychia in children: a clinical and histopathologic study of
40 cases. J Am Acad Dermatol. 1999;41(1):17-22.
27. Makkar HS, Frieden IJ. Congenital melanocytic nevi: an update
for the pediatrician. Curr Opin Pediatr. 2002;14(4):397-403.
28. Marghoob AA, Schoenbach SP, Kopf AW, et al. Large congenital
melanocytic nevi and the risk for the development of malignant melanoma:
a prospective study. Arch Dermatol. 1996;132(2):170-175.
29. Ingordo V, Gentile C, Iannazzone SS, et al. Congenital melanocytic
nevus: an epidemiologic study in Italy. Dermatology. 2007;214(3):227-230.
30. Rajpar SF, Abdullah A, Lanigan SW. Er:YAG laser
resurfacing for inoperable medium-sized facial congenital melanocytic
naevi in children. Clin Exp Dermatol. 2007;32(2):159-161.
31. Menon K, Dusza SW, Marghoob AA, et al. Classification and prevalence
of pigmented lesions in patients with total-body photographs at
high risk of developing melanoma. J Cutan Med Surg. 2006;10(2):85-91.
32. Schaffer JV, Orlow SJ, Lazova R, Bolognia JL. Speckled lentiginous
nevus: within the spectrum of congenital melanocytic nevi. Arch
Dermatol. 2001;137(2):172-178.
33. Vidaurri-de la Cruz H, Happle R. Two distinct types of speckled lentiginous
nevi characterized by macular versus papular speckles. Dermatology. 2006;212(1):53-58.
34. Schaffer JV, Glusac EJ, Bolognia JL. The eclipse naevus:
tan centre with stellate brown rim. Br J Dermatol. 2001;145(6):1023-1026.
36. Grob JJ. The “ugly duckling” sign: identification
of the common characteristics of nevi in an individual as a basis
for melanoma screening. Arch Dermatol. 1998;134(1):103-104.
37. Bauer J, Garbe C. Acquired melanocytic nevi as risk factor
for melanoma development. A comprehensive review of epidemiological
data. Pigment Cell Res. 2003;16(3):297-306.
38. Tsao H, Bevona C, Goggins W, Quinn T. The transformation
rate of moles (melanocytic nevi) into cutaneous melanoma: a population-based
estimate. Arch Dermatol. 2003;139(3):282-288.
39. Strauss RM, Newton Bishop JA. Spontaneous involution
of congenital melanocytic nevi of the scalp. J Am Acad Dermatol. 2008;58(3):508-511.
40. Krengel S, Hauschild A, Schäfer T. Melanoma risk
in congenital melanocytic naevi: a systematic review. Br
J Dermatol. 2006;155(1):1-8.
41. Kanzler MH. Management of large congenital melanocytic nevi: art
versus science. J Am Acad Dermatol. 2006;54(5):874-876.
42. Marghoob AA, Agero AL, Benvenuto-Andrade C, Dusza SW. Large
congenital melanocytic nevi, risk of cutaneous melanoma, and prophylactic
surgery. J Am Acad Dermatol. 2006;54(5):868-870.
43. Hale EK, Stein J, Ben-Porat L, et al. Association of melanoma and
neurocutaneous melanocytosis with large congenital melanocytic naevi—results
from the NYU-LCMN registry. Br J Dermatol. 2005;152(3):512-517.
44. Bett BJ. Large or multiple congenital melanocytic nevi:
occurrence of cutaneous melanoma in 1008 persons. J Am Acad
Dermatol. 2005;52(5):793-797.
45. Marghoob AA, Dusza S, Oliveria S, Halpern AC. Number
of satellite nevi as a correlate for neurocutaneous melanocytosis
in patients with large congenital melanocytic nevi. Arch
Dermatol. 2004;140(2):171-175.
46. Agero AL, Benvenuto-Andrade C, Dusza SW, et al. Asymptomatic
neurocutaneous melanocytosis in patients with large congenital melanocytic
nevi: a study of cases from an Internet-based registry. J
Am Acad Dermatol. 2005;53(6):959-65.
47. Bett BJ. Large or multiple congenital melanocytic nevi:
occurrence of neurocutaneous melanocytosis in 1008 persons. J
Am Acad Dermatol. 2006;54(5):767-777.
48. Foster RD, Williams ML, Barkovich AJ, et al. Giant congenital
melanocytic nevi: the significance of neurocutaneous melanosis in
neurologically asymptomatic children. Plast Reconstr Surg. 2001;107(4):933-941.
49. Tannous ZS, Mihm MC, Sober AJ, Duncan LM. Congenital melanocytic
nevi: clinical and histopathologic features, risk of melanoma, and
clinical management. J Am Acad Dermatol. 2005;52(2):197-203.
50. Tromberg J, Bauer B, Benvenuto-Adrade C, Marghoob AA. Congenital
nevi needing treatment. Dermatol Ther. 2005;18(2):136-150.
51. Ostertag JU, Quaedvlieg PJ, Kerckhoffs FE, et al. Congenital naevi
treated with erbium:YAG laser (Derma K) resurfacing in neonates:
clinical results and review of the literature. Br J Dermatol. 2006;154(5):889-895.
52. De Raeve LE, Claes A, Ruiter DJ, et al. Distinct phenotypic changes
between the superficial and deep component of giant congenital melanocytic
naevi: a rationale for curettage. Br J Dermatol. 2006;154(3):485-492.
53. Dragieva G, Hafner J, Künzi W, et al. Malignant
melanoma in a large congenital melanocytic nevus 9 years after dermabrasion
in childhood. Dermatology. 2006;212(2):208-209.
54. Leech SN, Bell H, Leonard N, Jones SL, et al. Neonatal giant congenital
nevi with proliferative nodules: a clinicopathologic study and literature
review of neonatal melanoma. Arch Dermatol. 2004;140(1):83-88.
55. Strouse JJ, Fears TR, Tucker MA, Wayne AS. Pediatric melanoma:
risk factor and survival analysis of the Surveillance, Epidemiology
and End Results Database. J Clin Oncol. 2005;23(21):4735-4741.
56. Ries LAG, Melbert D, Krapcho M, et al. SEER Cancer Statistics
Review, 1975-2004, National Cancer Institute. Bethesda, MD. http://seer.
cancer.gov/csr/1975_2004/, based
on November 2006 SEER data submission, posted to the SEER Web site,
2007.
57. Huynh PM, Grant-Kels JM, Grin CM. Childhood melanoma: update
and treatment. Int J Dermatol. 2005;44(9):715-723.
58. Lange JR, Balch CM. Melanoma in children: heightened awareness
of an uncommon but often curable malignancy. Pediatrics. 2005;115(3):802-803.
59. Ferrari A, Bono A, Baldi M, et al. Does melanoma behave
differently in younger children than in adults? A retrospective
study of 33 cases of childhood melanoma from a single institution. Pediatrics. 2005;115(3):649-654.
60. Roaten JB, Partrick DA, Bensard D, et al. Survival in sentinel lymph
node-positive pediatric melanoma. J Pediatr Surg. 2005;40(6):988-992.
61. Leman JA, Evans A, Mooi W, MacKie RM. Outcomes and pathological
review of a cohort of children with melanoma. Br J Dermatol. 2005;152(6):1321-1323.
62. Leung AK. Mongolian spots in Chinese children. Int
J Dermatol. 1988;27(2):106-108.
63. Hanson M, Lupski J, Hicks J, Metry D. Association of dermal
melanocytosis with lysosomal storage disease. Arch Dermatol. 2003;139(7):916-920.
64. Hori Y, Takayama O. Circumscribed dermal melanoses: classification
and histologic features. Dermatol Clin. 1988;6(2):315-326.
65. Shaffer D, Walker K, Weiss GR. Malignant melanoma in a Hispanic
male with nevus of Ota. Dermatology. 1992;185(2):146-150.
66. Watanabe S, Takahashi H. Treatment of nevus of Ota with
the Q-switched ruby laser. N Engl J Med. 1994;331(26):1745-1750.
67. Ber Rahman S, Bhawan J. Lentigo. Int J Dermatol. 1996;35(4):229-239.
68. Landau M. Krafchik BR. The diagnostic value of café-au-lait macules.
J Am Acad Dermatol. 1999;40(6):877-890.
69. Ahn JS, Kim SD, Hwang JH, et al. Halo-like disappearance
of Mongolian spot combined with café-au-lait spot. Pediatr
Dermatol. 1998;15(1):70-71.
70. Korf BR. Diagnostic outcome in children with multiple café au lait
spots. Pediatrics. 1992;90(6):924-927.
71. Person JR, Longcope C. Becker’s nevus: an androgen-mediated hyperplasia
with increased androgen receptors. J Am Acad Dermatol. 1984;10(2
Pt 1):235-238.
72. Carlson JA, Grabowski R, Mu XC. Possible mechanisms of hypopigmentation
in lichen sclerosus. Am J Dermatopathol. 2002;24(2):97-107.
73. Schaffer JV, Bolognia JL. The treatment of hypopigmentation
in children. Clin Dermatol. 2003;21(4):296-310.
74. Spritz RA. The genetics of generalized vitiligo and associated autoimmune
diseases. Pigment Cell Res. 2007;20(4):271-278.
75. Jin Y, Mailloux CM, Gowan K, et al. NALP1 in vitiligo-associated
multiple autoimmune disease. N Engl J Med. 2007;356(12):1216-1225.
76. Vanderhooft SL, Francis JS, Pagon RA, et al. Prevalence
of hypopigmented macules in a healthy population. J Pediatr. 1996;129(3):355-361.
77. Karabiber H, Sasmaz S, Turanli G, Yakinci C. Prevalence
of hypopigmented maculae and café-au-lait spots in idiopathic
epileptic and healthy children. J Child Neurol. 2002;17(1):57-59.
78. Lombillo VA, Sybert VP. Mosaicism in cutaneous pigmentation. Curr
Opin Pediatr. 2005;17(4):494-500.
79. Nehal KS, PeBenito R, Orlow SJ. Analysis of 54 cases of
hypopigmentation and hyperpigmentation along the lines of Blaschko. Arch
Dermatol. 1996;132(10):1167-1170.